Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NUDT1 | P36639 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1128906 | 0.81 | NPC1 (0.33) | HTTLMNANPC1RAB9A | |
| SCHEMBL4283192 | 0.78 | ESR1 (0.41) | HTTNUDT1NPC1RAB9AHRH4 | |
| SCHEMBL1128920 | 0.74 | NPC1 (0.46) | NUDT1LMNANPC1RAB9ACYP1A2 | |
| SCHEMBL7341936 | 0.72 | ACHE (0.39) | HTTNUDT1NPC1RAB9AHRH4 | |
| SCHEMBL1128497 | 0.72 | NPC1 (0.45) | LMNANPC1RAB9ATRPV1 | |
| SCHEMBL1128996 | 0.68 | NPC1 (0.44) | LMNANPC1RAB9AHRH4 | |
| SCHEMBL13394501 | 0.67 | GAA (0.42) | HTTLMNANPC1RAB9AHRH4 | |
| SCHEMBL26203737 | 0.66 | GABRA1 (0.42) | LMNANOS3NOS1NOS2 | |
| SCHEMBL1128775 | 0.66 | LMNA (0.41) | LMNANPC1RAB9ATRPV1 | |
| SCHEMBL1129053 | 0.66 | NPC1 (0.45) | LMNANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2282762-A2 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | Intermune, Inc. (US) | 2011-02-16 | — | — | EP | disclosed |
| WO-2009142842-A2 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION | INTERMUNE, INC. (US) | 2009-11-26 | — | — | WO | disclosed |